Clinical trial
A Randomized, Multicenter Study Comparing Post-Transplant KPD Regimen Consolidation With No Consolidation in Newly Diagnosed Multiple Myeloma (NDMM) Transplant-eligible Patients
NCT06879379 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Multicenter Study Comparing Post-Transplant KPD Regimen Consolidation With No Consolidation in Newly Diagnosed Multiple Myeloma (NDMM) Transplant-eligible Patients
- Lead sponsor
- Peking University People's Hospital
- Phase
- Phase 2/3
- Overall status
- Recruiting
- Start date
- March 31, 2025
- Completion date
- March 31, 2029
- Enrollment
- 202 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
multiple myeloma, newly diagnosed